Biology of Blood and Marrow Transplantation
Volume 15, Issue 9 , Pages 1014-1025 , September 2009

An Approach to Predicting Hematopoietic Stem Cell Transplantation Outcome Using HLA-Mismatch Information Mapped on Protein Structure Data

  • Małgorzata Dudkiewicz

      Affiliations

    • Department of Experimental Design and Bioinformatics, Warsaw University of Life Sciences Warsaw, Poland
    • Corresponding Author InformationCorrespondence and reprint requests: Małgorzata Dudkiewicz, Warsaw University of Life Sciences, Department of Experimental Design and Bioinformatics, 159 Nowoursynowska, 02-776 Warsaw, Poland.
  • ,
  • Piotr Malanowski

      Affiliations

    • Central Bone Marrow Donor and Cord Blood Registry, POLTRANSPLANT, Warsaw, Poland
  • ,
  • Jarosław Czerwin´ski

      Affiliations

    • Central Bone Marrow Donor and Cord Blood Registry, POLTRANSPLANT, Warsaw, Poland
  • ,
  • Krzysztof Pawłowski

      Affiliations

    • Department of Experimental Design and Bioinformatics, Warsaw University of Life Sciences Warsaw, Poland
    • Nencki Institute of Experimental Biology, Warsaw, Poland

Received 24 February 2009 ,Accepted 11 May 2009.

  • Image Result

    Survival curves for patients with GVHD (gray) and without GVHD (black) receiving transplants from unrelated donors with 2 kinds of HLA-B mismatch, B∗2702/2705 and B∗3501/3503.

    Survival curves for patients with GVHD (gray) and without GVHD (black) receiving transplants from unrelated donors with 2 kinds of HLA-B mismatch, B∗2702/2705 and B∗3501/3503.

  • Image Result

    Comparison of survival probability for patients from groups distinguished on the basis of donor matching level: Lr match, low-resolution match (allele mismatch); Lr MM, low-resolution mismatch (antige

    Comparison of survival probability for patients from groups distinguished on the basis of donor matching level: Lr match, low-resolution match (allele mismatch); Lr MM, low-resolution mismatch (antigen mismatch); DBMM, double mismatch (in 2 loci); FM, full-match–high-resolution match.

  • Image Result
    A, Structure substitution scheme: several candidate conformations of EBV peptide–ball-and-stick representation (1) presented by the original MHC B∗3501 ribbon representation (2) and the HLA-B alleles

    A, Structure substitution scheme: several candidate conformations of EBV peptide–ball-and-stick representation (1) presented by the original MHC B∗3501 ribbon representation (2) and the HLA-B alleles listed in Table 3. B, TCR–MHC contact region. Residues in the ball-and-stick representation were considered during contact energy calculations. Red, presented peptide; yellow, MHC; blue, TCR.

  • Image Result
    Results of energy minimization for constructed TCR–pMHC complexes for the 5 alleles evaluated. The y-axis represents the calculated energy of TCR–MHC contacts and TCR–-peptide contacts, according to f

    Results of energy minimization for constructed TCR–pMHC complexes for the 5 alleles evaluated. The y-axis represents the calculated energy of TCR–MHC contacts and TCR–-peptide contacts, according to formula (1). The NX5 structure was used as a template. 2702, 2705, 3501 and 3503 are TCR–pMHC complex models discussed in the text. 3508-ELS is a TCR–pMHC complex (B∗3508/EBVp) that does not activate T cells. 3508-NX5pep is a TCR–pMHC complex (B∗3508/EBVp) with peptide presented in conformation specific for B∗3501. X5ORG is a TCR–pMHC complex (B∗3501/EBVp) triggering T cell reaction.

  • Image Result
    Contact energies for the 5 Å zone without ligand and with only TCR and MHC residues, according to formula (2). Complexes were reconstructed on the template of the 1NX5.pdb file.

    Contact energies for the 5 Å zone without ligand and with only TCR and MHC residues, according to formula (2). Complexes were reconstructed on the template of the 1NX5.pdb file.

  • Image Result
    The molecular surface of the TCR–MHC contact zone with the presented EBV peptide depicted using a ball-and-stick model. TCR chain A, orange; chain B, blue; HLA chain A, grey

    The molecular surface of the TCR–MHC contact zone with the presented EBV peptide depicted using a ball-and-stick model. TCR chain A, orange; chain B, blue; HLA chain A, grey

  • Image Result
    Residues of MHC class I making contact on TCR (sorted by MHC residues) based on the known structures of TCR–pMHC complexes (according to Rudolph et al. [9]) and a proximity parameter of 5 Å. SNP B∗350

    Residues of MHC class I making contact on TCR (sorted by MHC residues) based on the known structures of TCR–pMHC complexes (according to Rudolph et al. [9]) and a proximity parameter of 5 Å. SNP B∗3501/3503 and B∗27-2/2705 also are shown (A105, 104, 101, and A141). The following MHC residues made the most contacts on TCR residues: A58, A59, A62, A65, A66, A69, A69, A70, A72, A73, A75, A76, A79, A146, A 147, A149, A150, A151, A152, A154, A 155, A158, A159, A162, A163, A166, A167, and A170.

  • Image Result
    Aligned sequences of 4 analyzed alleles of HLA-B. A, Amino acid differences between alleles of the same group (B2702-B2705 [black] and B3501-B3503 [blue]). B, Amino acid differences between alleles be

    Aligned sequences of 4 analyzed alleles of HLA-B. A, Amino acid differences between alleles of the same group (B2702-B2705 [black] and B3501-B3503 [blue]). B, Amino acid differences between alleles belonging to the separate HLA groups (B27 vs B35).

  • Image Result
    Comparison of survival curves for 2 groups of HSCT recipients who received transplants from B∗3501/3503 mismatched donors (MM 3501/3503; dotted line) and from B∗2702/2705 mismatched donors (MM 2702/27

    Comparison of survival curves for 2 groups of HSCT recipients who received transplants from B∗3501/3503 mismatched donors (MM 3501/3503; dotted line) and from B∗2702/2705 mismatched donors (MM 2702/2705; solid line) (n = 18).

  • Image Result
    Comparison of survival probability for patients from groups distinguished on the basis of the mismatched HLA locus: MMA, patients receiving transplants from HLA-A–mismatched donors; FM, patients recei

    Comparison of survival probability for patients from groups distinguished on the basis of the mismatched HLA locus: MMA, patients receiving transplants from HLA-A–mismatched donors; FM, patients receiving transplants from fully matched donors; DBMM, patients receiving transplants from donors mismatched at more than 1 locus. A, Curves plotted based on the whole data set. B, Curves plotted based on only the IHWG data. C, Curves plotted for only the Polish patients.

  • Image Result
    Survival curves for patients receiving transplants from donors mismatched in MHC class I or class II and for the fully matched control group.

    Survival curves for patients receiving transplants from donors mismatched in MHC class I or class II and for the fully matched control group.

 Financial disclosure: See Acknowledgments on page 1024.

PII: S1083-8791(09)00248-1

doi: 10.1016/j.bbmt.2009.05.011

Biology of Blood and Marrow Transplantation
Volume 15, Issue 9 , Pages 1014-1025 , September 2009